EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 24th, 2018 • Neos Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is entered into as of October 23, 2018 (the “Effective Date”) by and between NEURX PHARMACEUTICALS LLC, a limited liability company incorporated under the laws of Texas, with its principal place of business at 15 Gazelle Field, San Antonio, TX 78258 (“NeuRx”) and NEOS THERAPEUTICS, INC., a Delaware corporation, with its principal place of business at 2940 N. Hwy 360 Suite 400, Grand Prairie, TX 75050 (“Neos”). NeuRx and Neos are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
